{"id":"https://openalex.org/W2083322751","doi":"https://doi.org/10.1111/j.1528-1157.2000.tb02163.x","title":"An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action","display_name":"An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W2083322751","doi":"https://doi.org/10.1111/j.1528-1157.2000.tb02163.x","mag":"2083322751","pmid":"https://pubmed.ncbi.nlm.nih.gov/10768292"},"language":"en","primary_location":{"id":"doi:10.1111/j.1528-1157.2000.tb02163.x","doi":"https://doi.org/10.1111/j.1528-1157.2000.tb02163.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1528-1157.2000.tb02163.x","pdf_url":null,"source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090976373","display_name":"Richard P. Shank","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Richard P. Shank","raw_affiliation_strings":["The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A","The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A","institution_ids":[]},{"raw_affiliation_string":"The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086909091","display_name":"Joseph F. Gardocki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph F. Gardocki","raw_affiliation_strings":["The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023111405","display_name":"Anthony J. Streeter","orcid":"https://orcid.org/0000-0003-2378-2968","observed_orcids":["https://orcid.org/0000-0003-2378-2968"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony J. Streeter","raw_affiliation_strings":["The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070787633","display_name":"Bruce E. Maryanoff","orcid":"https://orcid.org/0000-0003-3590-2357","observed_orcids":["https://orcid.org/0000-0003-3590-2357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce E. Maryanoff","raw_affiliation_strings":["The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5090976373"],"corresponding_institution_ids":[],"apc_list":{"value":4360,"currency":"USD","value_usd":4360},"apc_paid":null,"fwci":18.2181,"has_fulltext":false,"cited_by_count":811,"citation_normalized_percentile":{"value":0.9968552,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"41","issue":"s1","first_page":"3","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":1.0},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.972000002861023},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7940000295639038},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.8389999866485596},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.4009999930858612},{"id":"https://openalex.org/keywords/seizure-models","display_name":"seizure models","score":0.6430000066757202},{"id":"https://openalex.org/keywords/cultured-neurons","display_name":"cultured neurons","score":0.8569999933242798},{"id":"https://openalex.org/keywords/allosteric-modulation","display_name":"allosteric modulation","score":0.9739999771118164},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.8598292469978333},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.8419622182846069},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7180502414703369},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.6921561360359192},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.630956768989563},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5390308499336243},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.4485713541507721},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.43271946907043457},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4296703040599823},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3195905089378357},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2208108901977539},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1153784692287445},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09387972950935364},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005071","descriptor_name":"Evoked Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008564","descriptor_name":"Membrane Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015220","descriptor_name":"Calcium Channels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015222","descriptor_name":"Sodium Channels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018079","descriptor_name":"Receptors, GABA","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018092","descriptor_name":"Kainic Acid Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018092","descriptor_name":"Kainic Acid Receptors","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018408","descriptor_name":"Patch-Clamp Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D026941","descriptor_name":"Sodium Channel Blockers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1528-1157.2000.tb02163.x","doi":"https://doi.org/10.1111/j.1528-1157.2000.tb02163.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1528-1157.2000.tb02163.x","pdf_url":null,"source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},{"id":"pmid:10768292","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10768292","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W34455977","https://openalex.org/W184474482","https://openalex.org/W1768249453","https://openalex.org/W1964769688","https://openalex.org/W1971931358","https://openalex.org/W1973491611","https://openalex.org/W1974311184","https://openalex.org/W1978922204","https://openalex.org/W1982450423","https://openalex.org/W1988702459","https://openalex.org/W1993706660","https://openalex.org/W2004951945","https://openalex.org/W2008051831","https://openalex.org/W2018710288","https://openalex.org/W2022924617","https://openalex.org/W2027341988","https://openalex.org/W2032515511","https://openalex.org/W2037894465","https://openalex.org/W2040481962","https://openalex.org/W2046895642","https://openalex.org/W2048986915","https://openalex.org/W2055854702","https://openalex.org/W2066698854","https://openalex.org/W2071674869","https://openalex.org/W2087421035","https://openalex.org/W2088276984","https://openalex.org/W2091325286","https://openalex.org/W2093023279","https://openalex.org/W2106828113","https://openalex.org/W2106979056","https://openalex.org/W2113215554","https://openalex.org/W2116171370","https://openalex.org/W2121413985","https://openalex.org/W2141637053","https://openalex.org/W2159276547","https://openalex.org/W2165630646","https://openalex.org/W2170554092","https://openalex.org/W2326760408","https://openalex.org/W2916674156","https://openalex.org/W4248382813","https://openalex.org/W4285719527","https://openalex.org/W4295332804"],"related_works":["https://openalex.org/W2165630646","https://openalex.org/W6982662541","https://openalex.org/W2027959147","https://openalex.org/W2069763147","https://openalex.org/W2115438929","https://openalex.org/W4253389366","https://openalex.org/W52838215","https://openalex.org/W2744798873","https://openalex.org/W2108682124","https://openalex.org/W4223999250"],"abstract_inverted_index":{"In":[0,25],"this":[1],"overview,":[2],"we":[3,27,65],"discuss":[4],"the":[5,42,70,74],"discovery":[6],"and":[7,22,36,41,47,93,99],"development":[8],"of":[9,18,39,44,59,62,73,77],"topiramate":[10],"(TPM)":[11],"as":[12],"an":[13],"anticonvulsant,":[14],"including":[15],"notable":[16],"aspects":[17],"its":[19,29],"chemical,":[20],"biologic,":[21],"pharmacokinetic":[23],"properties.":[24],"particular,":[26],"highlight":[28],"anticonvulsant":[30,75],"profile":[31],"in":[32],"traditional":[33],"seizure":[34],"tests":[35],"animal":[37],"models":[38],"epilepsy":[40],"results":[43],"recent":[45],"electrophysiological":[46],"biochemical":[48],"studies":[49],"using":[50],"cultured":[51],"neurons":[52],"that":[53,81],"have":[54],"revealed":[55],"a":[56,67],"unique":[57],"combination":[58],"pharmacologic":[60],"properties":[61],"TPM.":[63],"Finally,":[64],"present":[66],"hypothesis":[68],"for":[69],"mechanistic":[71],"basis":[72],"activity":[76],"TPM,":[78],"which":[79],"proposes":[80],"TPM":[82],"binds":[83],"to":[84],"certain":[85],"membrane":[86],"ion":[87],"channel":[88,97],"proteins":[89],"at":[90],"phosphorylation":[91],"sites":[92],"thereby":[94],"allosterically":[95],"modulates":[96],"conductance":[98],"secondarily":[100],"inhibits":[101],"protein":[102],"phosphorylation.":[103]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":23},{"year":2021,"cited_by_count":20},{"year":2020,"cited_by_count":179},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":25},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":24},{"year":2015,"cited_by_count":33},{"year":2014,"cited_by_count":27},{"year":2013,"cited_by_count":28},{"year":2012,"cited_by_count":23}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}